Cowen Starts SciClone Pharmaceuticals (SCLN) at Outperform
SCLN Hot Sheet
Rating Summary:1 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Cowen initiates coverage on SciClone Pharmaceuticals (NASDAQ: SCLN) with an Outperform.
For an analyst ratings summary and ratings history on SciClone Pharmaceuticals click here. For more ratings news on SciClone Pharmaceuticals click here.
Shares of SciClone Pharmaceuticals closed at $4.54 yesterday, with a 52 week range of $3.30-$6.88.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
For an analyst ratings summary and ratings history on SciClone Pharmaceuticals click here. For more ratings news on SciClone Pharmaceuticals click here.
Shares of SciClone Pharmaceuticals closed at $4.54 yesterday, with a 52 week range of $3.30-$6.88.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: Capstone Starts Facebook (FB) at Hold as Premium Multiple Not Justified
- Goldman Sachs Boosts Numbers on PVH Corp (PVH) After Q1 Beat
- Needham & Company Reiterates a 'Buy' on UQM Technologies (UQM); Increasing EV Adoption
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
